Published in J Virol on May 01, 1990
The alphaviruses: gene expression, replication, and evolution. Microbiol Rev (1994) 16.68
Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. J Virol (2000) 2.41
Bc1-2 protects mice against fatal alphavirus encephalitis. Proc Natl Acad Sci U S A (1996) 2.31
Viral determinants of age-dependent virulence of Sindbis virus for mice. J Virol (1993) 1.95
Deduced consensus sequence of Sindbis virus strain AR339: mutations contained in laboratory strains which affect cell culture and in vivo phenotypes. J Virol (1996) 1.88
Luciferase imaging of a neurotropic viral infection in intact animals. J Virol (2003) 1.83
Mechanism of altered Sindbis virus neurovirulence associated with a single-amino-acid change in the E2 Glycoprotein. J Virol (1991) 1.80
Identification of a putative alphavirus receptor on mouse neural cells. J Virol (1991) 1.78
An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector. J Virol (2003) 1.56
Infection of neonatal mice with sindbis virus results in a systemic inflammatory response syndrome. J Virol (1999) 1.56
Persistence of viral RNA in mouse brains after recovery from acute alphavirus encephalitis. J Virol (1992) 1.51
Identification of genes involved in the host response to neurovirulent alphavirus infection. J Virol (2001) 1.39
Control of Sindbis virus infection by antibody in interferon-deficient mice. J Virol (2000) 1.16
Virulence variation among isolates of western equine encephalitis virus in an outbred mouse model. J Gen Virol (2009) 1.11
Antiviral activity of alpha interferon in Sindbis virus-infected cells is restored by anti-E2 monoclonal antibody treatment. J Virol (1995) 1.09
Effects of anti-E2 monoclonal antibody on sindbis virus replication in AT3 cells expressing bcl-2. J Virol (1995) 0.98
Genome-wide RNAi screen identifies SEC61A and VCP as conserved regulators of Sindbis virus entry. Cell Rep (2013) 0.93
Complexity of the microglial activation pathways that drive innate host responses during lethal alphavirus encephalitis in mice. ASN Neuro (2012) 0.84
Immunization with nonstructural proteins promotes functional recovery of alphavirus-infected neurons. J Virol (1997) 0.83
Crystal structure of aura virus capsid protease and its complex with dioxane: new insights into capsid-glycoprotein molecular contacts. PLoS One (2012) 0.78
Sindbis Virus Can Exploit a Host Antiviral Protein To Evade Immune Surveillance. J Virol (2016) 0.76
The Gordon Wilson lecture: unique interactions between viruses, neurons and the immune system. Trans Am Clin Climatol Assoc (1996) 0.75
Interferon regulatory factor 2 protects mice from lethal viral neuroinvasion. J Exp Med (2016) 0.75
Detection of mrnas in sea urchin embryos by in situ hybridization using asymmetric RNA probes. Dev Biol (1984) 12.47
Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J Exp Med (1984) 10.66
Complete nucleotide sequence of the genomic RNA of Sindbis virus. Virology (1984) 6.60
Isolation and characterization of conditional-lethal mutants of Sindbis virus. Virology (1966) 6.30
Molecular basis of Sindbis virus neurovirulence in mice. J Virol (1988) 3.90
PERSISTENCE OF LYMPHOCYTIC CHORIOMENINGITIS VIRUS IN IMMUNE ANIMALS AND ITS RELATION TO IMMUNITY. J Exp Med (1936) 3.70
Sindbis virus: a newly recognized arthropodtransmitted virus. Am J Trop Med Hyg (1955) 3.34
Age-dependent resistance to viral encephalitis: studies of infections due to Sindbis virus in mice. J Infect Dis (1972) 2.56
The characterization fo the B-cell repertoire specific for the 2,4-dinitrophenyl and 2,4,6-trinitrophenyl determinants in neonatal BALB/c mice. J Exp Med (1975) 2.32
Basis of neurovirulence in Sindbis virus encephalomyelitis of mice. Lab Invest (1988) 2.05
Sindbis virus mutants selected for rapid growth in cell culture display attenuated virulence in animals. Science (1984) 2.00
Molecular analysis of Sindbis virus pathogenesis in neonatal mice by using virus recombinants constructed in vitro. J Virol (1988) 1.96
Role of the immune response in age-dependent resistance of mice to encephalitis due to Sindbis virus. J Infect Dis (1976) 1.86
A single nucleotide change in the E2 glycoprotein gene of Sindbis virus affects penetration rate in cell culture and virulence in neonatal mice. Proc Natl Acad Sci U S A (1986) 1.82
Alphavirus neurovirulence: monoclonal antibodies discriminating wild-type from neuroadapted Sindbis virus. J Virol (1985) 1.64
The pathogenesis of spinal cord involvement in the encephalomyelitis of mice caused by neuroadapted Sindbis virus infection. Lab Invest (1987) 1.63
PRODUCTION OF INTERFERON BY NEWBORN AND ADULT MICE INFECTED WITH SINDBIS VIRUS. Virology (1964) 1.50
Low pH-dependent Sindbis virus-induced fusion of BHK cells: differences between strains correlate with amino acid changes in the E1 glycoprotein. Virology (1989) 1.46
Age-dependent resistance of mice to sindbis virus infection: viral replication as a function of host age. Infect Immun (1971) 1.45
Specificity of the inflammatory response in viral encephalitis. I. Adoptive immunization of immunosuppressed mice infected with Sindbis virus. J Exp Med (1972) 1.39
Patterned acquisition of the antibody repertoire: diversity of the hemagglutinin-specific B-cell repertoire in neonatal BALB/c mice. Proc Natl Acad Sci U S A (1979) 1.24
Sindbis virus infection in man. Report of a case with recovery of virus from skin lesions. S Afr Med J (1963) 1.17
Preferential expression of variable region heavy chain gene segments by predominant 2,4-dinitrophenyl-specific BALB/c neonatal antibody clonotypes. Proc Natl Acad Sci U S A (1986) 1.13
Age-dependent resistance of mice to sindbis virus infection: reticuloendothelial role. J Reticuloendothel Soc (1973) 1.06
The pathogenesis of Sindbis virus infection in athymic nude mice. J Immunol (1979) 1.05
Late acquisition of a germ line antibody specificity. Nature (1976) 1.05
Ontogeny of B cell precursors responding to alpha 1- greater than 3 dextran in BALB/c mice. J Immunol (1984) 1.04
Ockelbo disease in Sweden: epidemiological, clinical, and virological data from the 1982 outbreak. Am J Trop Med Hyg (1984) 1.01
Strains of Sindbis-like virus isolated from culicine mosquitoes in the Union of South Africa. I. Isolation and properties. S Afr Med J (1956) 1.00
Interference mediated by a variant of Sindbis virus. I. Isolation of an avirulent variant and in vivo interference. J Infect Dis (1973) 0.98
Late clonal selection and expansion of the TEPC-15 germ-line specificity. J Exp Med (1980) 0.92
Cells with natural killer activity in the cerebrospinal fluid of normal mice and athymic nude mice with acute Sindbis virus encephalitis. J Immunol (1986) 0.84
Ockelbo disease: arthralgia 3-4 years after infection with a Sindbis virus related agent. Lancet (1986) 0.80
Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature (1993) 4.81
Molecular basis of Sindbis virus neurovirulence in mice. J Virol (1988) 3.90
Antibody-mediated clearance of alphavirus infection from neurons. Science (1991) 3.70
Mechanism of suppression of cell-mediated immunity by measles virus. Science (1996) 3.55
Antigenic shift of visna virus in persistently infected sheep. Science (1977) 3.17
Slow virus replication: the role of macrophages in the persistence and expression of visna viruses of sheep and goats. J Gen Virol (1982) 2.87
Characterization of Shigella dysenteriae 1 (Shiga) toxin purified by anti-Shiga toxin affinity chromatography. Infect Immun (1980) 2.82
Binding of Sindbis virus to cell surface heparan sulfate. J Virol (1998) 2.82
Selection of a fixative for identifying T cell subsets, B cells, and macrophages in paraffin-embedded mouse spleen. J Immunol Methods (1983) 2.82
Alphavirus-induced apoptosis in mouse brains correlates with neurovirulence. J Virol (1996) 2.65
Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol (1992) 2.52
Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to macrophages. Infect Immun (1983) 2.52
Modulation of cell death by Bcl-XL through caspase interaction. Proc Natl Acad Sci U S A (1998) 2.42
Role of the immune response in recovery from Sindbis virus encephalitis in mice. J Immunol (1977) 2.32
Bc1-2 protects mice against fatal alphavirus encephalitis. Proc Natl Acad Sci U S A (1996) 2.31
Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice. N Engl J Med (1977) 2.23
Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol (1996) 2.22
Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol (1994) 2.21
Purification and biological characterization of shiga toxin from Shigella dysenteriae 1. Infect Immun (1982) 2.21
Infection of monocytes during measles. J Infect Dis (1993) 2.14
Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol (1993) 2.09
Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol (1998) 2.05
Basis of neurovirulence in Sindbis virus encephalomyelitis of mice. Lab Invest (1988) 2.05
Apoptosis as a cause of death in measles virus-infected cells. J Virol (1995) 1.97
Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons. Science (2001) 1.95
Viral determinants of age-dependent virulence of Sindbis virus for mice. J Virol (1993) 1.95
Role of the immune response in age-dependent resistance of mice to encephalitis due to Sindbis virus. J Infect Dis (1976) 1.86
Use of a new CD4-positive HeLa cell clone for direct quantitation of infectious human immunodeficiency virus from blood cells of AIDS patients. J Infect Dis (1991) 1.85
Neurovirulent strains of Alphavirus induce apoptosis in bcl-2-expressing cells: role of a single amino acid change in the E2 glycoprotein. Proc Natl Acad Sci U S A (1994) 1.84
Virus mutation during 'slow infection': temporal development and characterization of mutants of visna virus recovered from sheep. J Gen Virol (1978) 1.80
Mechanism of altered Sindbis virus neurovirulence associated with a single-amino-acid change in the E2 Glycoprotein. J Virol (1991) 1.80
Slow virus infection: replication and mechanisms of persistence of visna virus in sheep. J Infect Dis (1977) 1.78
Identification of a putative alphavirus receptor on mouse neural cells. J Virol (1991) 1.78
Abnormal T-cell subset proportions in vitamin-A-deficient children. Lancet (1993) 1.75
In vitro evidence for a dual role of tumor necrosis factor-alpha in human immunodeficiency virus type 1 encephalopathy. Ann Neurol (1995) 1.70
Large-plaque mutants of Sindbis virus show reduced binding to heparan sulfate, heightened viremia, and slower clearance from the circulation. J Virol (2000) 1.69
Alphavirus neurovirulence: monoclonal antibodies discriminating wild-type from neuroadapted Sindbis virus. J Virol (1985) 1.64
The pathogenesis of spinal cord involvement in the encephalomyelitis of mice caused by neuroadapted Sindbis virus infection. Lab Invest (1987) 1.63
Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo. J Virol (1998) 1.62
Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains. J Infect Dis (1999) 1.62
Measles virus infection of thymic epithelium in the SCID-hu mouse leads to thymocyte apoptosis. J Virol (1996) 1.61
A double labeling technique for performing immunocytochemistry and in situ hybridization in virus infected cell cultures and tissues. J Virol Methods (1985) 1.60
Acute measles in patients with and without neurological involvement: distribution of measles virus antigen and RNA. J Infect Dis (1988) 1.59
Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy. Neurology (1993) 1.59
Profile of Escherichia coli O157:H7 pathogen responsible for hamburger-borne outbreak of hemorrhagic colitis and hemolytic uremic syndrome in Washington. J Clin Microbiol (1993) 1.58
Biological characterization of the virus causing leukoencephalitis and arthritis in goats. J Gen Virol (1980) 1.53
Persistence of viral RNA in mouse brains after recovery from acute alphavirus encephalitis. J Virol (1992) 1.51
Age dependence of viral expression: comparative pathogenesis of two rodent-adapted strains of measles virus in mice. Infect Immun (1974) 1.51
Measles encephalomyelitis--clinical and immunologic studies. N Engl J Med (1984) 1.50
Efficiency of in situ hybridization as a function of probe size and fixation technique. J Virol Methods (1985) 1.47
Low pH-dependent Sindbis virus-induced fusion of BHK cells: differences between strains correlate with amino acid changes in the E1 glycoprotein. Virology (1989) 1.46
Long term intraparenchymal Ig secretion after acute viral encephalitis in mice. J Immunol (1992) 1.45
Release of Shiga toxin from Shigella dysenteriae 1 by polymyxin B. Infect Immun (1983) 1.43
Monoclonal antibody cure and prophylaxis of lethal Sindbis virus encephalitis in mice. J Virol (1986) 1.43
Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann Neurol (1999) 1.42
Specificity of the inflammatory response in viral encephalitis. I. Adoptive immunization of immunosuppressed mice infected with Sindbis virus. J Exp Med (1972) 1.39
Mouse hepatitis virus-induced recurrent demyelination. A preliminary report. Arch Neurol (1975) 1.39
The effect of complement depletion on the course of Sindbis virus infection in mice. J Immunol (1978) 1.38
Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response. Clin Immunol Immunopathol (1993) 1.38
Early immune responses in visna, a slow viral disease of sheep. J Infect Dis (1978) 1.37
Regulation of lymphocyte homing into the brain during viral encephalitis at various stages of infection. J Immunol (1996) 1.36
Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody. Nat Med (1999) 1.35
Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann Neurol (1988) 1.34
Attenuation of Sindbis virus neurovirulence by using defined mutations in nontranslated regions of the genome RNA. J Virol (1992) 1.34
The role of CD8(+) T cells and major histocompatibility complex class I expression in the central nervous system of mice infected with neurovirulent Sindbis virus. J Virol (2000) 1.34
Intracerebral cytokine mRNA expression during fatal and nonfatal alphavirus encephalitis suggests a predominant type 2 T cell response. J Immunol (1994) 1.32
Neutralizing antibody spectrum determines the antigenic profiles of emerging mutants of visna virus. Infect Immun (1981) 1.31
Differences between C57BL/6 and BALB/cBy mice in mortality and virus replication after intranasal infection with neuroadapted Sindbis virus. J Virol (2000) 1.30
The synthesis and structure of visna virus DNA. Virology (1979) 1.30
Distinct HIV-1 env sequences are associated with neurotropism and neurovirulence. Curr Top Microbiol Immunol (1995) 1.29
Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide. J Virol (2000) 1.29
Chimeric Sindbis-Ross River viruses to study interactions between alphavirus nonstructural and structural regions. J Virol (1996) 1.28
Molecular analysis of neurovirulent strains of Sindbis virus that evolve during persistent infection of scid mice. J Virol (1993) 1.28
Inhibition of nitric oxide synthesis increases mortality in Sindbis virus encephalitis. J Virol (1996) 1.25
Immunoglobulins in the cerebrospinal fluid: changes during acute viral encephalitis in mice. J Immunol (1981) 1.23
Monoclonal antibodies to the E1 and E2 glycoproteins of Sindbis virus: definition of epitopes and efficiency of protection from fatal encephalitis. J Gen Virol (1988) 1.23
The role of complement in viral infections. II. the clearance of Sindbis virus from the bloodstream and central nervous system of mice depleted of complement. J Infect Dis (1980) 1.23
Sindbis virus-induced neuronal death is both necrotic and apoptotic and is ameliorated by N-methyl-D-aspartate receptor antagonists. J Virol (2001) 1.22
Prospective study of the magnitude and duration of changes in tuberculin reactivity during uncomplicated and complicated measles. Pediatr Infect Dis J (1987) 1.21
Isolation and characterization of monoclonal antibodies to Shiga toxin. Infect Immun (1983) 1.21
Immunocytochemical identification and quantitation of the mononuclear cells in the cerebrospinal fluid, meninges, and brain during acute viral meningoencephalitis. J Exp Med (1984) 1.21
Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry. J Neuroimmunol (1997) 1.20
Development of antibody to measles virus polypeptides during complicated and uncomplicated measles virus infections. J Virol (1984) 1.20
The role of complement in viral infections. III. Activation of the classical and alternative complement pathways by Sindbis virus. J Immunol (1980) 1.20
Induction of apoptosis by Sindbis virus occurs at cell entry and does not require virus replication. J Virol (1999) 1.19
Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.19
Host modification of Sindbis virus sialic acid content influences alternative complement pathway activation and virus clearance. J Immunol (1981) 1.19
Cellular immune responses during complicated and uncomplicated measles virus infections of man. Clin Immunol Immunopathol (1984) 1.18
Cytokine production in vitro and the lymphoproliferative defect of natural measles virus infection. Clin Immunol Immunopathol (1991) 1.18
Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study. Ann Intern Med (1983) 1.18
Amino acid changes in the Sindbis virus E2 glycoprotein that increase neurovirulence improve entry into neuroblastoma cells. J Virol (1997) 1.18
Cellular immune response to viral infection: in vitro studies of lymphocytes from mice infected with Sindbis virus. Cell Immunol (1973) 1.17
Prolonged measles virus shedding in human immunodeficiency virus-infected children, detected by reverse transcriptase-polymerase chain reaction. J Infect Dis (2001) 1.16
Control of Sindbis virus infection by antibody in interferon-deficient mice. J Virol (2000) 1.16
Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination. N Engl J Med (1987) 1.12
Isolation of brain parenchymal lymphocytes for flow cytometric analysis. Application to acute viral encephalitis. J Immunol Methods (1991) 1.12
Experimental viral polymyositis: age dependency and immune responses to Ross River virus infection in mice. Neurology (1981) 1.10
Roles of immunoglobulin valency and the heavy-chain constant domain in antibody-mediated downregulation of Sindbis virus replication in persistently infected neurons. J Virol (1995) 1.10